logo BDSP

Base documentaire


  1. Fecal occult blood testing for colorectal cancer can we afford not to do this ?

    Article - En anglais

    Current practice guidelines recommend annual fecal occult blood test screening for colorectal cancer in the average-risk population over the age of 50.

    Efficacy of fecal occult blood test screening is supported by several controlled prospective trials and case-control studies.

    Implementation of this recommendation, in combination with periodic flexible sigmoidoscopy every 5 years, is feasible, affordable, highly effective, and has the potential for reducing colorectal cancer mortality by at least 50%. With over 50,000 Americans dying of this malignancy each year, we cannot afford not to do this.

    Mots-clés Pascal : Carcinome, Côlon, Rectum, Risque élevé, Dépistage, Sang, Asymptomatique, Fèces, Sensibilité, Efficacité, Analyse avantage coût, Etude critique, Homme, Tumeur maligne, Appareil digestif pathologie, Intestin pathologie, Côlon pathologie, Rectum pathologie, Economie santé

    Mots-clés Pascal anglais : Carcinoma, Colon, Rectum, High risk, Medical screening, Blood, Asymptomatic, Feces, Sensitivity, Efficiency, Cost benefit analysis, Critical study, Human, Malignant tumor, Digestive diseases, Intestinal disease, Colonic disease, Rectal disease, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0238759

    Code Inist : 002B24O06. Création : 11/06/1997.